The MEA point of care diagnostics market is expected to grow from US$ 2,484.03 million in 2021 to US$ 5,433.77 million by 2028; it is estimated to grow at a CAGR of 11.8% from 2021 to 2028.
The UAE, South Africa, and Saudi Arabia are major economies in MEA region. Growth in the use of home-based poc devices is expected to escalate the market growth. The increasing awareness about point of care testing is bringing the test conveniently and quickly to the patient at home. Most clinicians recognize POC testing as a requirement for early detection of life-threatening situations because laboratory results can be made available in real-time. POC diagnostic and monitoring devices are anticipated to become universal in-home setups as well as at doctor’s offices or hospitals, in low- and middle-income countries. Consumers are frequently using smartphones as platform devices. The health and monitoring applications of smartphones commonly include imaging, sensing, and diagnostics. Although glucose meters are widely used in home settings by diabetic patients, they can also be repurposed to perform common clinical assays such as immunoassays, molecular diagnostics, and enzymatic assays. The rise in geriatric population has resulted in increased expenditure on healthcare for health checkups, disease diagnoses, and treatments. The most constant health problems affecting this population include digestive disorders, cardiovascular diseases, bone and joint diseases, diabetes, and different types of cancer. The people of this age group claim diagnostic testing on a regular basis, owing to their low immunity and metabolism. Therefore, these factors have increased the demand of POCs for diagnostic purposes across MEA region.In case of COVID-19, MEA is highly affected specially Turkey. Economic uncertainties and ongoing conflicts are worsening the condition in the region. For instance, countries such as Syria, Libya, and Yemen are suffering violent conflict and cannot implement any public health measures. Iran was in deep economic recession due to the US sanctions. Also, the major source of economic stabilization in Middle East countries is oil production and export. However, the recent pandemic is causing turbulence to the economies of the Middle East region. A sudden drop in domestic and external demand for goods and products, especially crude oil, and halted production due to labor shortage, are major impacts observed in the region. The Saudi government policies are favored of domestic pharmaceutical manufacturers including not any import duties on raw materials & intermediate products and interest-free funding support the growth of the pharmaceutical market in this region. Similarly, increasing incidence of COVID-19 create huge demand for kits and reagent used in detection of covid-19 virus. In April 2020, BGI Group, a Chinese genomics company, and Group-42, a UAE technology company, unveiled a new massive-throughput laboratory in the UAE to help with testing and diagnosis of the novel coronavirus. According to BGI, the lab will use RT-PCR diagnostic kits that have been approved by medical regulatory authorities in China, Europe, the United States, and Japan. As point of care diagnostics kits are majorly used in detection of novel coronavirus, so there was high impact of covid-19 on the point of care diagnostics market.
With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the MEA point of care diagnostics market. The MEA point of care diagnostics market is expected to grow at a good CAGR during the forecast period. 
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
MEA Point of Care Diagnostics Market Segmentation
MEA Point of Care Diagnostics Market – By Product
- Glucose Monitoring Products
- Infectious Disease Testing Products
- HIV Testing
- Influenza Testing
- Sexually Transmitted Disease (STD) Testing
- Hepatitis C Testing
- Healthcare-Associated Infection (HAI) Testing
- Tropical Disease Testing
- Respiratory Infection Testing
- Other Infectious Disease Testing
- Cardiometabolic Testing Products
- Pregnancy and Fertility Testing Products
- Coagulation Testing Products
- Tumor/Cancer Marker Testing Products
- Cholesterol Testing Products
- Urinalysis Testing Products
- Hematology Testing Products
- Other POC Products
MEA Point of Care Diagnostics Market – By Prescription Mode
- Prescription-Based Testing
- OTC Testing
MEA Point of Care Diagnostics Market – By End User
- Professional Diagnostic Centers
- Hospitals
- Clinical Laboratories
- Outpatient Healthcare
- Ambulatory Care Settings
- Home Care
- Research Laboratories
- Others
MEA Point of Care Diagnostics Market, by Country
- UAE
- Saudi Arabia
- South Africa
- Rest of MEA
MEA Point of Care Diagnostics Market -Companies Mentioned
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product, Prescription Mode, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Saudi Arabia
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Point of Care Diagnostics Market – By Product
1.3.2 MEA Point of Care Diagnostics Market – By Prescription Mode
1.3.3 MEA Point of Care Diagnostics Market – By End User
1.3.4 MEA Point of Care Diagnostics Market – By Country
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Point of Care Diagnostics Market – Market Landscape
4.1 Overview
4.2 MEA PEST Analysis
5. MEA Point of Care Diagnostics Market – Key Industry Dynamics
5.1 Key Market Drivers
5.1.1 Surging Prevalence of Infectious Diseases
5.1.2 Escalating Product Launches and Product Developments
5.1.3 Mounting Number of CLIA-waived POC tests
5.2 Market Restraints
5.2.1 Rising Product Recalls in Market
5.3 Market Opportunities
5.3.1 Rising Number of Conferences and Events
5.4 Future Trends
5.4.1 Growth in the Use of Home-Based POC Devices
5.5 Impact Analysis
6. Point of Care Diagnostics Market – MEA Analysis
6.1 MEA Point of Care Diagnostics Market Revenue Forecast and Analysis
7. MEA Point of Care Diagnostics Market Analysis– by Product
7.1 Overview
7.2 MEA Point of Care Diagnostics Market, By Product 2020 & 2028 (%)
7.3 Glucose Monitoring
7.3.1 Overview
7.3.2 Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
7.4 Infectious Disease Testing
7.4.1 Overview
7.4.2 Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.3 HIV Testing
7.4.3.1 Overview
7.4.3.2 HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.4 Influenza Testing
7.4.4.1 Overview
7.4.4.2 Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.5 Sexually Transmitted Disease (STD) Testing
7.4.5.1 Overview
7.4.5.2 Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.6 Hepatitis C Testing
7.4.6.1 Overview
7.4.6.2 Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.7 Healthcare-Associated Infection (HAI) Testing
7.4.7.1 Overview
7.4.7.2 Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.8 Tropical Disease Testing
7.4.8.1 Overview
7.4.8.2 Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.9 Respiratory Infection Testing
7.4.9.1 Overview
7.4.9.2 Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.4.10 Other Infectious Disease
7.4.10.1 Overview
7.4.10.2 Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
7.5 Cardiometabolic Testing
7.5.1 Overview
7.5.2 Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.6 Pregnancy and Fertility Testing
7.6.1 Overview
7.6.2 Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.7 Coagulation Testing
7.7.1 Overview
7.7.2 Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.8 Tumor/Cancer Marker Testing
7.8.1 Overview
7.8.2 Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.9 Cholesterol Testing
7.9.1 Overview
7.9.2 Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.10 Urinalysis Testing
7.10.1 Overview
7.10.2 Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
7.11 Haematology Testing
7.11.1 Overview
7.11.2 Haematology Testing Revenue and Forecasts to 2028 (US$ Mn)
7.12 Other POC
7.12.1 Overview
7.12.2 Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
8. MEA Point of Care Diagnostics Market Analysis– by Prescription Mode
8.1 Overview
8.2 MEA Point of Care Diagnostics Market, By Prescription Mode 2020 & 2028 (%)
8.3 Prescription-Based Testing Market
8.3.1 Overview
8.3.2 Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
8.4 OTC Testing Market
8.4.1 Overview
8.4.2 OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
9. MEA Point of Care Diagnostics Market Analysis– by End User
9.1 Overview
9.2 MEA Point of Care Diagnostics Market, By End User 2020 & 2028 (%)
9.3 Professional Diagnostic Centers
9.3.1 Overview
9.3.2 Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.3 Hospitals
9.3.3.1 Overview
9.3.3.2 Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.4 Clinical Laboratories
9.3.4.1 Overview
9.3.4.2 Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.5 Outpatient Healthcare
9.3.5.1 Overview
9.3.5.2 Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
9.3.6 Ambulatory Care Settings
9.3.6.1 Overview
9.3.6.2 Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
9.4 Home Care
9.4.1 Overview
9.4.2 Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
9.5 Research Laboratories
9.5.1 Overview
9.5.2 Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
9.6 Others
9.6.1 Overview
9.6.2 Others Market Revenue and Forecasts to 2028 (US$ Mn)
10. MEA Point of Care Diagnostics Market – Country Analysis
10.1 MEA: Point of care Diagnostics Market
10.1.1 Overview
10.1.2 MEA: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
10.1.3 UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.1 UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.3.2 UAE: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.3.2.1 UAE: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.3.3 UAE: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.3.4 UAE: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.3.4.1 UAE: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.4 Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.1 Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.4.2 Saudi Arabia: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.4.2.1 Saudi Arabia: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.4.3 Saudi Arabia: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.4.4 Saudi Arabia: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.4.4.1 Saudi Arabia: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.5 South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.1 South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.5.2 South Africa: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.5.2.1 South Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.5.3 South Africa: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.5.4 South Africa: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.5.4.1 South Africa: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
10.1.6 Rest of MEA: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.1 Rest of MEA: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Rest of MEA: Point of Care Diagnostics Market, By Product, 2019-2028 (USD Million)
10.1.6.2.1 Rest of MEA: Infectious Disease Testing Products Market, By Infectious Disease Testing, 2019-2028 (USD Million)
10.1.6.3 Rest of MEA: Point of Care Diagnostics Market, By Prescription Mode, 2019-2028 (USD Million)
10.1.6.4 Rest of MEA: Point of Care Diagnostics Market, By End User, 2019-2028 (USD Million)
10.1.6.4.1 Rest of MEA: Professional Diagnostic Centres Market, By Professional Diagnostic Centres, 2019-2028 (USD Million)
11. Impact of COVID-19 Pandemic on MEA Point of Care Diagnostics Market
11.1 MEA: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Organic Growth Strategies
12.2.1 Overview
12.3 Inorganic Growth Strategies
12.3.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Danaher
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 BIO-RAD LABORATORIES INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Abbott
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Johnson and Johnson Services, Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Siemens AG
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 BD
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 bioMerieux SA
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4
13.8.5 Financial Overview
13.8.6 SWOT Analysis
13.8.7 Key Developments
13.9 Polymer Technology Systems, Inc. (PTS)
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Nova Biomedical
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. MEA Point of Care Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Table 2. UAE: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 3. UAE: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 4. UAE: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 5. UAE: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 6. UAE: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 7. Saudi Arabia: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 8. Saudi Arabia: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 9. Saudi Arabia: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 10. Saudi Arabia: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 11. Saudi Arabia: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 12. South Africa: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 13. South Africa: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 14. South Africa: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 15. South Africa: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 16. South Africa: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 17. Rest of MEA: Point of Care Diagnostics Market, By Product - Revenue and Forecast to 2028 (USD Million)
Table 18. Rest of MEA: Infectious Disease Testing Products Market, By Infectious Disease Testing- Revenue and Forecast to 2028 (USD Million)
Table 19. Rest of MEA: Point of Care Diagnostics Market, By Prescription Mode - Revenue and Forecast to 2028 (USD Million)
Table 20. Rest of MEA: Point of Care Diagnostics Market, By End User - Revenue and Forecast to 2028 (USD Million)
Table 21. Rest of MEA: Professional Diagnostic Centers Market, By Professional Diagnostic Centers- Revenue and Forecast to 2028 (USD Million)
Table 22. Recent Organic Developments the Point of Care Diagnostics Market
Table 23. Recent Inorganic Developments in the Point of Care Diagnostics Market
Table 24. Glossary of Terms
LIST OF FIGURES
Figure 1. MEA Point of Care Diagnostics Market Segmentation
Figure 2. MEA Point of Care Diagnostics Market Segmentation, By Country
Figure 3. MEA Point of Care Diagnostics Market Overview
Figure 4. Prescription-Based Testing Segment Held Largest Share of MEA Point of Care Diagnostics Market
Figure 5. UAE to Show Significant Growth During Forecast Period
Figure 6. MEA: PEST Analysis
Figure 7. Impact Analysis of Driver and Restraints Pertaining to MEA Point of Care Diagnostics Market
Figure 8. MEA Point of Care Diagnostics Market – Revenue Forecast and Analysis
Figure 9. MEA Point of Care Diagnostics Market, by Products 2020 & 2028 (%)
Figure 10. MEA Glucose Monitoring Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 11. MEA Infectious Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. MEA HIV Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. MEA Influenza Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. MEA Sexually Transmitted Disease (STD) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. MEA Hepatitis C Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 16. MEA Healthcare-Associated Infection (HAI) Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 17. MEA Tropical Disease Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. MEA Respiratory Infection Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. MEA Others Infection Disease Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. MEA Cardiometabolic Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. MEA Pregnancy and Fertility Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 22. MEA Coagulation Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. MEA Tumor/Cancer Marker Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. MEA Cholesterol Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 25. MEA Urinalysis Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 26. MEA Haematology Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 27. MEA Other POC Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 28. MEA Point of Care Diagnostics Market, by Prescription Mode 2020 & 2028 (%)
Figure 29. MEA Prescription-Based Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 30. MEA OTC Testing Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 31. MEA Point of Care Diagnostics Market, by End User 2020 & 2028 (%)
Figure 32. MEA Professional Diagnostic Centers Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 33. MEA Hospitals Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 34. MEA Clinical Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 35. MEA Outpatient Healthcare Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 36. MEA Ambulatory Care Settings Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 37. MEA Home Care Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 38. MEA Research Laboratories Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 39. MEA Others Market Revenue and Forecasts to 2028 (US$ Mn)
Figure 40. MEA: Point of Care Diagnostics Market, by Key Country- Revenue (2020) (USD Million)
Figure 41. MEA: Point of Care Diagnostics Market, By Country, 2020 & 2028 (%)
Figure 42. UAE: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 43. Saudi Arabia: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 44. South Africa: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 45. Rest of MEA: Point of Care Diagnostics Market - Revenue and Forecast to 2028 (USD Million)
Figure 46. Impact of COVID-19 Pandemic in MEA Country Markets
- Abbott
- BD
- bioMerieux SA
- BIO-RAD LABORATORIES INC.
- Danaher
- F. HOFFMANN-LA ROCHE LTD.
- Johnson and Johnson Services, Inc.
- Nova Biomedical
- Polymer Technology Systems, Inc. (PTS)
- Siemens AG
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Middle East and Africa Point of Care Diagnostics Market
Jul 2021
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Jul 2021
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Jul 2021
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography
Jul 2021
Lung Cancer Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Therapy Type (Noninvasive and Minimally Invasive), Indication (Non-Small Cell Lung Cancer and Small Cell Lung Cancer), End User (Hospitals, Oncology Clinics, Research Centers, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)